Results

Total Results: 2,890 records

Showing results for "disease".

301. DEMENTIA INCLUDING ALZHEIMER'S #04 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/dementia-horizon-scan-high-impact-1406.pdf
     February 01, 2015 - These medications do not change the underlying disease process. … Paul, MN), and the Alzheimer’s Disease Cooperative Study (La Jolla, CA). … Alzheimer's disease fact sheet. [internet]. … Alzheimer's Disease Cooperative Study (ADCS) . … Alzheimer's disease. [internet].

302. Topic Suggestion Description | Effective Health Care Program
     effectivehealthcare.ahrq.gov/get-involved/nominated-topics/copd-is-common-and-respiratory-failure-due-to-copd-is-an-increasingly-common-disorder-use-of-non-invasive-positive-pressure-ventilation-nppv-for-patients-with-respiratory-failure-due-to-exacerbatons-of-copd-several-trials-and
     March 11, 2008 - (you may select more than one category if appropriate)   My question relates to a very common disease … or problem   People with this disease or problem have considerable health or financial hardships   There … or condition:   Screening or diagnosis/identification for a particular disease, or risk assessment for … a disease   Risks or harms that can come from a disease identification tool or test   Diagnostic tests … and tools   Diagnosis of co-occurring diseases   Intervention (such as a drug treatment, therapy, device

303. Cad-Pci-Bypass Surveillance (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cad-pci-bypass_surveillance.pdf
     May 01, 2013 - Effectiveness of Percutaneous Coronary Interventions and Coronary Artery Bypass Grafting for Coronary Artery Disease … and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial. … Randomized trial of stents versus bypass surgery for left main coronary artery disease. … or left main coronary artery disease were randomized CABG or PCI with drug-eluting stents 1800 … or left main coronary artery disease were randomized CABG or PCI with drug-eluting stents 1800

304. DEMENTIA INCLUDING ALZHEIMER'S #04 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/04_dementia_potential_high_impact_2012-12-10.pdf
     January 01, 2012 - fatal, patients can live as long as 20 years after diagnosis and often have coexisting age-related diseases … regression or slowing of disease progression. … Mild Cognitive Impairment (MCI) due to Alzheimer's Disease Workgroup. … Alzheimer's disease fact sheet. [internet]. … Memory and insulin in early Alzheimer's disease (MAIN).

305. Test-Performance-Metrics Appendixes (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/test-performance-metrics_appendixes.pdf
     January 01, 2005 - Metrics The basic definitions of test performance are based upon a 2×2 cross tabulation of the “true disease … Status Disease* No Disease* (Index) Medical Test Suggestive of disease (“positive”) “TP” (= … The reference test is assumed to have negligible misclassification of the true disease status. … A-3 If a given medical test has very good ability to predict the “true disease status,” its positive … relative to the odds of a positive test in those without disease.4 It can be computed in terms of

306. Topic Brief: Supplemental Oxygen Prescribing Practices (pdf file)
     effectivehealthcare.ahrq.gov/system/files/docs/topic-brief-supplemental-oxygen.pdf
     October 16, 2020 - (COPD), and in 2010 the Centers for Disease Control and Prevention predicted that costs associated … What is the comparative effectiveness and harms of oxygen devices in adults with chronic lung disease … Effectiveness and harms of oxygen devices Population Adults with chronic lung disease (e.g., COPD … Setting Outpatient Outpatient Abbreviations: COPD=chronic obstructive pulmonary disease; LOX=liquid … Chronic Obstructive Pulmonary Disease Costs. Centers for Disease Controla and Prevention.

307. Fifth Journal Supplement on Research Methods: Patient-Centered Health Outcomes in Rare Diseases | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/rare-diseases-outcomes
     July 24, 2014 - Fifth Journal Supplement on Research Methods: Patient-Centered Health Outcomes in Rare Diseases … Fifth Journal Supplement on Research Methods: Patient-Centered Health Outcomes in Rare Diseases

308. Cardiac Troponins Used as Diagnostic and Prognostic Tests in Patients With Kidney Disease | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/renal-function/research
     August 11, 2014 - Comments Report Cardiac Troponins Used as Diagnostic and Prognostic Tests in Patients With Kidney Disease … systematically review the literature on the use of cardiac troponin levels in patients with chronic kidney disease … Hazard ratios (HR) adjusted at least for age and coronary artery disease or risk equivalents were pooled … Prognostic Value of Cardiac Troponin in Patients With Chronic Kidney Disease Without Suspected Acute

309. Supplemental Project To Assess the Transparency of Reporting Requirements: Omega-3 Fatty Acids and Cardiovascular Disease | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/transparency-omega-3/research
     June 01, 2017 - Project To Assess the Transparency of Reporting Requirements: Omega-3 Fatty Acids and Cardiovascular Disease … Related Report: Omega-3 Fatty Acids and Cardiovascular Disease: An Updated Systematic Review (2016) … Project to Assess the Transparency of Reporting Requirements: Omega-3 Fatty Acids and Cardiovascular Disease

310. Layout 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/renal-artery-stenosis_executive.pdf
     October 01, 2006 - and ischemic kidney disease. … among the elderly and those with diffuse atherosclerotic vascular diseases. … A history or markers of some cardiovascular diseases were associated with increased mortality, poor clinical … and parenchymal kidney disease. … predicted cardiovascular mortality in patients with coronary artery disease and RAS. disease Diagnostic

311. Topic 0505 Genetic Testing for Developmental Diseases NSD FINAL_SJ (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND-0594-131115.pdf
     March 13, 2013 - Topic 0505 Genetic Testing for Developmental Diseases NSD FINAL_SJ … § Genetic Testing for Developmental Diseases Nomination Summary Document … Results of Topic Selection Process & Next Steps  The topic, Genetic Testing for Developmental Diseases

312. Topic Suggestion Description | Effective Health Care Program
     effectivehealthcare.ahrq.gov/get-involved/nominated-topics/disease-modifying-therapies-multiple-sclerosis
     May 14, 2021 - Description Date submitted: May 14, 2021 Comparative Effectiveness and Safety of Disease-Modifying … We need more compressive comparative effectiveness and safety information about disease-modifying therapy

313. Untitled (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/heart-disease-ace-inhibitor-arb_surveillance.pdf
     July 06, 2015 - / (37638) 4 Arterial Occlusive Diseases/ (25088) 5 Peripheral Vascular Diseases/ (11282) 6 Vascular … Diseases/ (27218) 7 Atherosclerosis/ (22731) 8 Cardiovascular Diseases/ (106963) 9 Carotid Artery … Diseases/ (18735) 10 ((preserved adj left) or (stable adj cad) or (stable adj chd) or (stable adj … disorders (coronary disease, peripheral artery disease, carotid atherosclerosis)], did not enroll at … disease, peripheral artery disease, carotid atherosclerosis), 3) enrolled patients who had preserved

314. Topic Suggestion Description | Effective Health Care Program
     effectivehealthcare.ahrq.gov/get-involved/nominated-topics/for-patients-with-crohns-disease-what-treatments-or-therapies-alone-or-in-conjunction-with-one-another-provide-the-highest-rate-of-disease-management-with-the-lowest-risk-of-long-term-complications-particularly-in-young-women
     March 10, 2009 - For patients with Crohn's disease, what treatments or therapies, alone or in conjunction with one another … (For example, an ethnic group, stage or severity of a disease.) … Avoiding further surgery, higher quality of life for the duration of the disease. … Digestive diseases are difficult to evaluate given their internal existence. … There should be more concrete evidence surrounding the disease and available therapies.

315. Enzyme-Replacement Therapies for Lysosomal Storage Diseases | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/lysosomal-storage-diseases-therapies
     October 05, 2011 - Enzyme-Replacement Therapies for Lysosomal Storage Diseases Timeline October 04, 2011 … Technical Brief Archived Enzyme-Replacement Therapies for Lysosomal Storage Diseases

316. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/cad-women-treatment_research-protocol.pdf
     September 29, 2011 - Coronary disease risk factors such as diabetes, chronic kidney disease, or other comorbid disease? … Coronary disease risk factors such as diabetes, chronic kidney disease, or other comorbid disease? … Coronary disease risk factors such as diabetes, chronic kidney disease, or other comorbid disease? … risk factors such as diabetes, chronic kidney disease, or other comorbid disease o Angiographic-specific … Proposed Search Strategy cardiovascular diseases OR heart diseases OR heart OR cardiovas* OR cardiac

317. DEMENTIA INCLUDING ALZHEIMER'S #04 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/dementia_hi_impact.pdf
     January 01, 2012 - Priority Area 04: Dementia (including Alzheimer’s disease) 1. … fatal, patients can live as long as 20 years after diagnosis and often have coexisting age-related diseases … for which no disease modifying therapy currently exists. … perspective, also pointed out that this technology has the potential to change the diagnostic pathways for diseases … purported ability to rule out AD in patients who have symptoms that are characteristic of several diseases

318. Effectiveness of Screening and Treatment of Subclinical Hypothyroidism or Hyperthyroidism | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/hypothyroidism-hyperthyroidism-screening-treatment/research-protocol
     March 10, 2010 - Causes of subclinical hyperthyroidism are similar to overt hyperthyroidism and include Graves’ disease … to overt disease to life-threatening complications, 6 and thus identification of those in the early … Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. … The Colorado Thyroid Disease Prevalence Study. Arch Intern Med 2000;160:526-34. … Screening for Thyroid Disease. Rockville, MD: U.S.

319. Topic Brief: Benefits of Pulmonary Rehabilitation (pdf file)
     effectivehealthcare.ahrq.gov/system/files/docs/benefits_pulmonary_rehab_topic_brief.pdf
     October 28, 2020 - Issue: Pulmonary rehabilitation is considered a key management strategy for many chronic lung diseases … Population Adults with chronic lung diseases (COPD, interstitial lung disease, bronchiectasis, cystic … Adults with chronic lung diseases (COPD, interstitial lung disease, bronchiectasis, cystic fibrosis … Population Adults with chronic lung diseases (COPD, interstitial lung disease, bronchiectasis, cystic … diseases and cancers. 2b.

320. Erythropoiesis-Stimulating-Agents-Utilization Research (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/erythropoiesis-stimulating-agents-utilization_research.pdf
     February 01, 2011 - Trends in the utilization of erythropoiesis-stimulating agents among Medicare beneficiaries with kidney disease … Anemia in chronic kidney disease: causes, diagnosis, treatment. … Normalization of hemoglobin level in patients with chronic kidney disease and anemia. … Correction of anemia with epoetin alfa in chronic kidney disease. … International Classification of Diseases (ICD-9) procedure, Current Procedural Terminology (CPT ),